Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FIYY
Barclays ETN+ FI Enhanced Global High Yield ETN Series B
FIYY
|
+$1.49B |
| 2 |
FFEU
Barclays ETN+ FI Enhanced Europe 50 ETN Series C
FFEU
|
+$423M |
| 3 |
SLB Ltd
SLB
|
+$408M |
| 4 |
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
|
+$340M |
| 5 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FIGY
Barclays ETN+ FI Enhanced Global High Yield ETN
FIGY
|
+$1.59B |
| 2 |
FEEU
Barclays ETN+ FI Enhanced Europe 50 ETN
FEEU
|
+$464M |
| 3 |
Citigroup
C
|
+$340M |
| 4 |
American Express
AXP
|
+$206M |
| 5 |
CAA
CalAtlantic Group, Inc.
CAA
|
+$123M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.58% |
| 2 | Technology | 14.9% |
| 3 | Healthcare | 12.05% |
| 4 | Consumer Discretionary | 9.38% |
| 5 | Consumer Staples | 5.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Artisan Partners
APAM
$2.79B
| $58.5M | 0.08% |
1,756,648
-38,387
| -2% | -$1.38M |
|
152
Mastercard
MA
$502B
| $58.1M | 0.08% |
331,824
+5,666
| +2% | +$968K |
|
|
CADE
153
DELISTED
Cadence Bank
CADE
| $57.4M | 0.08% |
1,805,998
-37,097
| -2% | -$1.22M |
|
154
Meta Platforms (Facebook)
META
$1.42T
| $57.2M | 0.08% |
357,835
+65,876
| +23% | +$11.8M |
|
155
Vanguard FTSE Europe ETF
VGK
$30.7B
| $56.5M | 0.08% |
972,125
+77,328
| +9% | +$4.64M |
|
156
Helmerich & Payne
HP
$3.45B
| $56.2M | 0.07% |
844,400
+482,539
| +133% | +$32.5M |
|
157
RLJ Lodging Trust
RLJ
$1.86B
| $54.8M | 0.07% |
2,818,191
-50,769
| -2% | -$1.08M |
|
|
PC
158
DELISTED
PANASONIC CORP ADR (REP 1 SHR COM STK) (JP)
PC
| $54.5M | 0.07% |
3,856,454
+267,760
| +7% | +$3.79M |
|
|
ETFC
159
DELISTED
E*Trade Financial Corporation
ETFC
| $54.5M | 0.07% |
983,663
-21,247
| -2% | -$1.13M |
|
|
WMGI
160
DELISTED
Wright Medical Group Inc
WMGI
| $54.5M | 0.07% |
2,744,485
-98,732
| -3% | -$2.12M |
|
|
FIGY
161
DELISTED
Barclays ETN+ FI Enhanced Global High Yield ETN
FIGY
| $54.3M | 0.07% |
336,206
-9,348,140
| -97% | -$1.59B |
|
|
JHG
162
DELISTED
Janus Henderson
JHG
| $53.2M | 0.07% |
1,609,152
-31,623
| -2% | -$1.17M |
|
163
Integra LifeSciences
IART
$1.29B
| $53M | 0.07% |
956,830
-38,560
| -4% | -$2.02M |
|
164
Vanguard S&P 500 ETF
VOO
$979B
| $52.4M | 0.07% |
216,400
+49,966
| +30% | +$12.5M |
|
165
Henry Schein
HSIC
$9.77B
| $51.9M | 0.07% |
984,323
-56,472
| -5% | -$3.13M |
|
166
iShares MSCI Japan ETF
EWJ
$21.9B
| $51.7M | 0.07% |
851,719
+248
| +0% | +$15.2K |
|
167
Diageo
DEO
$49B
| $51.4M | 0.07% |
379,277
-43,205
| -10% | -$6.01M |
|
168
Regal Rexnord
RRX
$13.7B
| $51.3M | 0.07% |
699,538
-5,945
| -0.8% | -$447K |
|
|
MZTI
169
The Marzetti Company
MZTI
$2.93B
| $50.3M | 0.07% |
408,580
-8,661
| -2% | -$1.07M |
|
170
Cemex
CX
$17.1B
| $50.1M | 0.07% |
7,573,830
-505,100
| -6% | -$3.78M |
|
|
MDP
171
DELISTED
Meredith Corporation
MDP
| $48.7M | 0.06% |
904,928
-17,461
| -2% | -$1.04M |
|
172
Colgate-Palmolive
CL
$73.1B
| $48.6M | 0.06% |
678,491
+93,375
| +16% | +$6.72M |
|
|
AXE
173
DELISTED
Anixter International Inc
AXE
| $47.4M | 0.06% |
625,822
-8,719
| -1% | -$679K |
|
174
Core Laboratories
CLB
$488M
| $47.4M | 0.06% |
+438,014
| New | +$48.5M |
|
175
UMB Financial
UMBF
$11.1B
| $46.7M | 0.06% |
644,927
-9,625
| -1% | -$721K |
|
Similar funds
Ken Fisher's Q1 2018 Portfolio in Review
As of Q1 2018, Ken Fisher held 991 positions worth $75.4B, down 1.5% from $76.6B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Ken Fisher's Q1 2018 filing shows 69 new, 261 increased, 401 reduced and 162 closed positions. Its largest new stake was Barclays ETN+ FI Enhanced Global High Yield ETN Series B: 15,406,823 shares worth $1.49B. The largest sale was Barclays ETN+ FI Enhanced Global High Yield ETN, an estimated $1.59B.
By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
- Ken Fisher's largest Q1 2018 buy was Barclays ETN+ FI Enhanced Global High Yield ETN Series B: 15,406,823 shares worth $1.49B.
- Ken Fisher added most to SLB Ltd in Q1 2018, an estimated $408M increase.
- Ken Fisher's biggest Q1 2018 reduction was Barclays ETN+ FI Enhanced Global High Yield ETN, cutting an estimated $1.59B.
- Ken Fisher fully exited CalAtlantic Group, Inc. in Q1 2018, selling an estimated $123M.
- Ken Fisher's ten largest holdings make up 26% of its $75.4B portfolio in Q1 2018.
- Ken Fisher opened 69 new positions and closed 162 in Q1 2018.
- Ken Fisher's portfolio value fell 1.5% quarter-over-quarter to $75.4B.
Based on Fisher Asset Management's 13F filing for Q1 2018, filed 19 Apr 2018.